record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to stateno incoming links yet
record state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding typeNo entity list is declared.
evidence
source-boundexperimental · manual state transition; control details require source inspection · source-reported model organism
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition; control details require source inspection
evidence type
experimental
species
source-reported model organism
evidence spans
Anti-Amyloid Monoclonal Antibodies for Alzheimer's Disease: Evidence, ARIA Risk, and Precision Patient Selection. — Alzheimer's disease (AD) is the most common cause of dementia, pathologically defined by extracellular amyloid-β (Aβ) plaques and intracellular tau neurofibrillary tangles. Recent U.S. Food and Drug...
Alkhalifa AE; Al Mokhlf A; Ali H; Al-Ghraiybah NF; Syropoulou V. Journal of personalized medicine 2025. doi:10.3390/jpm15090437 · curator_source · 10.3390/jpm15090437
conditions
Provenance
source title
Alkhalifa AE; Al Mokhlf A; Ali H; Al-Ghraiybah NF; Syropoulou V. Journal of personalized medicine 2025. doi:10.3390/jpm15090437
doi
10.3390/jpm15090437
journal
Journal of personalized medicine
authors
Alkhalifa AE, Al Mokhlf A, Ali H, Al-Ghraiybah NF, Syropoulou V
Anti-Amyloid Monoclonal Antibodies for Alzheimer's Disease: Evidence, ARIA Risk, and Precision Patient Selection. — Alzheimer's disease (AD) is the most common cause of dementia, pathologically defined by extracellular amyloid-β (Aβ) plaques and intracellular tau neurofibrillary tangles. Recent U.S. Food and Drug...
vs_0cdd00b8a79bd2d9 · source:Alkhalifa AE; Al Mokhlf A; Ali H; Al-Ghraiybah NF; Syropoulou V. Journal of personalized medicine 2025. doi:10.3390/jpm15090437|section:curator_source · manual_curation
outgoing
No outgoing links.
incoming
No incoming links.
events
vev_c6584746f3a9de38finding.assertedManual finding added to frontier state
reviewer:will-blair-bot · 2026-05-06
reviewable changes
vpr_31a2cebaa5d38622finding.addManual finding added to frontier state
applied · reviewer:will-blair-bot · 2026-05-06
evaluations
No evaluation record targets this finding id.